Cancer cells with defective RB and CDKN2A are resistant to the apoptotic effects of rapamycin
| Title: | Cancer cells with defective RB and CDKN2A are resistant to the apoptotic effects of rapamycin |
|---|---|
| Authors: | Chakraborty, Sohag a, b, 1; Utter, Matthew B. a, b, 1; Frias, Maria A. a; Foster, David A. a, b, c, ∗ |
| Source: | In Cancer Letters 1 December 2021 522:164-170 |
| Database: | ScienceDirect |